"Welcome to the Rochester Ophthalmological Group, where our focus is on providing you with the medical and surgical eye care services you need in a friendly environment. Our educational background and clinical experience combine to achieve optimal results. Whether your goal is to manage an existing eye condition or discover a suitable method of correcting less-than-ideal vision, you can trust that we will approach your needs with compassion and thoughtfulness, the way we would want for ourselves and our own families. When you visit our Rochester ophthalmology practices, you are treated like an important member of the treatment team."

During the past decade, Rochester Ophthalmological Group, PC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rochester Ophthalmological Group, PC" #1 sponsor was "Aerie Pharmaceuticals" with 7 trials, followed by "Allergan" with 7 trials sponsored, "Santen Inc." with 4 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored and "Ocuphire Pharma, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Ophthalmological Group, PC" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Ophthalmological Group, PC" are "Ocular Hypertension" (11 trials), "Open Angle Glaucoma" (5 trials), "Dry Eye Syndromes" (3 trials), "Glaucoma" (3 trials) and "Keratoconjunctivitis Sicca" (2 trials). Many other conditions were trialed in "Rochester Ophthalmological Group, PC" in a lesser frequency.

Most popular intervention types in "Rochester Ophthalmological Group, PC" are "Drug" (25 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "AR-12286 Ophthalmic Solution 0.5%" (2 trials), "AR-13324 Ophthalmic Solution 0.01%" (2 trials), "AR-13324 Ophthalmic Solution 0.02%" (2 trials), "DE-117 Ophthalmic Solution" (2 trials) and "Latanoprost 0.005%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Ophthalmological Group, PC" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Rochester Ophthalmological Group, PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Rochester Ophthalmological Group, PC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Ophthalmological Group, PC, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".